A61Q19/00

POLYOL ESTERS FROM BIOBASED FEEDSTOCKS FOR USE AS EMOLLIENT IN PERSONAL CARE APPLICATIONS

Provided are personal care compositions comprising ester polyol esters, ester polyol esters, manufacturing methods thereof, and the use of ester polyol esters in personal care compositions.

POLYOL ESTERS FROM BIOBASED FEEDSTOCKS FOR USE AS EMOLLIENT IN PERSONAL CARE APPLICATIONS

Provided are personal care compositions comprising ester polyol esters, ester polyol esters, manufacturing methods thereof, and the use of ester polyol esters in personal care compositions.

INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC SEQUESTERING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A WEAK ACID FUNCTION
20230002590 · 2023-01-05 ·

Disclosed is a self-invertible inverse latex comprising an aqueous phase containing: a) a crosslinked anionic polyelectrolyte (P) including: —at least one first monomer unit derived from 2-methyl-2-[(1-oxo-2-propenyl) amino] 1-propanesulfonic acid in the form of a free or partially or totally salified acid; —at least one second monomer unit derived from at least one monomer selected from the elements of the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylic acid, itaconic acid, maleic acid, 3-methyl 3-[(1-oxo-2-propenyl) amino] butanoic acid, the carboxylic function of said monomers being in the free, partially salified or totally salified acid form; and —at least one third monomer unit derived from a polyethylenic crosslinking monomer (AR); b) ethylenediamine disuccinic acid in the form of trisodium salt.

INVERSE LATEX FOR A COSMETIC COMPOSITION COMPRISING A SPECIFIC SEQUESTERING AGENT AND A POLYELECTROLYTE COMBINING A STRONG ACID FUNCTION AND A WEAK ACID FUNCTION
20230002590 · 2023-01-05 ·

Disclosed is a self-invertible inverse latex comprising an aqueous phase containing: a) a crosslinked anionic polyelectrolyte (P) including: —at least one first monomer unit derived from 2-methyl-2-[(1-oxo-2-propenyl) amino] 1-propanesulfonic acid in the form of a free or partially or totally salified acid; —at least one second monomer unit derived from at least one monomer selected from the elements of the group consisting of acrylic acid, methacrylic acid, 2-carboxyethyl acrylic acid, itaconic acid, maleic acid, 3-methyl 3-[(1-oxo-2-propenyl) amino] butanoic acid, the carboxylic function of said monomers being in the free, partially salified or totally salified acid form; and —at least one third monomer unit derived from a polyethylenic crosslinking monomer (AR); b) ethylenediamine disuccinic acid in the form of trisodium salt.

TRPM8 MODULATORS

Disclosed are TRPM8 modulators as defined by formula (I) for achieving a cooling effect on skin and mucousa.

TRPM8 MODULATORS

Disclosed are TRPM8 modulators as defined by formula (I) for achieving a cooling effect on skin and mucousa.

NOVEL USE OF MILK EXOSOMES

The present invention relates to a novel use of milk exosomes, and more specifically, provides various uses of milk exosomes, such as in functional cosmetics, functional health food with various functions such as improving gut health and immunity, and drugs including a wound healing medication.

COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.

COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY

Peptide-based systems containing hydrophobic amino acids (e.g., tryptophan), charged amino acids (e.g., arginine), and/or sulfur-containing amino acids (e.g., cysteine), which can be used either alone or in combination with nanoparticles (e.g., gold or silver nanoparticles) for siRNA delivery into living cells are disclosed.

PPAR AGONIST COMPLEX AND METHODS OF USE
20230000759 · 2023-01-05 ·

Compositions and topical formulations comprising a PPAR agonist complex comprising glyceryl linoleate, glyceryl linolenate, xymenynic acid, and Pterocarpus marsupium bark extract are described herein. Methods of inducing skin barrier repair, increasing the biosynthesis of barrier lipids and proteins in the skin, stimulating hair growth, treating acne and combinations thereof utilizing the composition and topical formulations are also provided herein.